Plasma C-reactive protein levels and their relationship to anthropometric and lipid characteristics among children

Journal of Clinical Epidemiology

Volumn 56, Issue 1, 2003, Pages 94-100

  Wu, Der Min ^a   Chu, Nain Feng ^a   Shen, Muh Han ^a   Chang, Jin Biou ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Anthropometric; C reactive protein; Cardiovascular; Children; Risk factors

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLASMA PROTEIN; TRIACYLGLYCEROL;

ADOLESCENT; AGE; ALCOHOL CONSUMPTION; ANTHROPOMETRY; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CHILD DEVELOPMENT; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CORRELATION ANALYSIS; GENDER; HEART RATE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PUBERTY; SCHOOL CHILD; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ANTHROPOMETRY; BIOLOGICAL MARKERS; BODY HEIGHT; BODY MASS INDEX; BODY WEIGHT; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHILD; FEMALE; HUMANS; LIPIDS; MALE; MULTIVARIATE ANALYSIS; RISK FACTORS; SEX FACTORS; TAIWAN;

EID: 0037263718     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(02)00519-X     Document Type: Article

References (40)

1. Steel D.M., Whitehead A.S. The major acute phase reactants. C-reactive protein, serum amyloid P component and serum amyloid A protein Immunol Today. 15:1994;81-88.
2. Danesh J., Collins R., Appleby P.et al. Fibrinogen, C-reactive protein, albumin or white cell count. meta-analyses of prospective studies of coronary heart disease JAMA. 79:1998;1477-1482.
3. Ridker P.M., Rifai N., Pfeffer M.A.et al. Long-term effects of pravastatin on plasma concentration of C-reactive protein. Circulation. 100:1999;230-235.
4. Mendall M.A., Patel P., Ballam L.et al. C Reactive protein and its relation to cardiovascular risk factors. a population based cross sectional study BMJ. 312:1996;1061-1065.
5. Rohde L.E.P., Hennekens C.H., Ridker P.M. Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men. Am J Cardiol. 84:1999;1018-1022.
6. Tracy R.P., Lemaitre R.N., Pasty B.M.et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. results from the Cardiovascular Health Study and the Rural Health Promotion Project Arterioscler Thromb Vasc Biol. 17:1997;1121-1127.
7. Palosuo T., Husman T., Koistinen J.et al. C-reactive protein in population samples. Acta Med Scand. 220:1986;175-179.
8. Alvarez C., Ramos A. Lipids, lipoproteins, and apoproteins in serum during infection. Clin Chem. 32:1986;142-145.
9. Visser M., Bouter L.M., McQuillan G.M.et al. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 282:1999;2131-2135.
10. Ford E.S. Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care. 22:1999;1971-1977.
11. Haverkate F., Thompson S.G., Pyke S.D.et al. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disability Angina Pectoris Study Group. Lancet. 349:1997;462-466.
12. Ridker P.M., Glynn R.J., Hennekens C.H. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation. 97:1998;2007-2011.
13. Lagrand W.K., Visser C.A., Hermens W.T.et al. C-reactive protein as a cardiovascular risk factor. more than an epiphenomenon? Circulation. 100:1999;96-102.
14. Cook D.G., Mendall M.A., Whincup P.H.et al. C-reactive protein concentration in children. relationship to adiposity and other cardiovascular risk factors Atherosclerosis. 149:2000;139-150.
15. Ford E.S., Galuska D.A., Gillespie C.et al. C-reactive protein and body mass index in children. findings from the Third National Health and Nutrition Examination Survey, 1988-1994 J Pediatr. 138:2001;486-492.
16. Visser M., Bouter L.M., McQuillan G.M.et al. Low-grade systemic inflammation in overweight children. Pediatrics. 107:2001;E13.
17. Chu N.F., Rimm E.B., Wang D.J.et al. Relationship between anthropometric variable and lipid levels among school children. the Taipei Children Heart Study Int J Obes. 22:1998;66-72.
18. Chu N.F., Rimm E.B., Wang D.J.et al. Clustering of cardiovascular disease risk factors among obese schoolchildren. the Taipei Children Heart Study Am J Clin Nutr. 67:1998;1141-1146.
19. Richmond W. Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum. Clin Chem. 19:1973;1350-1356.
20. Stavropoulos W.S., Crouch R.D. A new calorimetric procedure for the determination of serum triglyceride. Clin Chem. 20:1974;857.
21. Wamick G.R., Benderson J., Albers J.J. Dextran sulfate-Mg precipitation procedure for quantification of high density lipoprotein-cholesterol. Clin Chem. 28:1982;1379-1388.
22. Friedewald W.T., Levy R., Fredrickson D.S. Estimation of the concentration of low density lipoprotein-cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem. 18:1972;499-502.
23. Marcovina S.M., Albers J.J., Dati F.et al. International federation of clinical chemistry standardization projects for measurements of apolipoprotein A-1 and B. Clin Chem. 18:1972;499-502.
24. Robert W.L., Sedrick R., Moulton L.et al. Evaluation of four automated high sensitivity C-reactive protein method. implications for clinical and epidemiological applications Clin Chem. 46:2000;461-468.
25. Castell J.V., Andus T., Kunz D.et al. Interleukin-6. the major regulator of acute-phase protein synthesis in man and rat Ann N Y Acad Sci. 557:1989;87-101.
26. Neumann F.J., Ott I., Gawaz M.et al. Cardiac release of cytokines and inflammatory responses in acute myocardial infraction. Circulation. 92:1995;748-755.
27. Gauldie J., Richards C., Northemann W.et al. IFNb2/BSF/IL-6 is the monocyte-derived HSF that regulates receptor specific acute phase gene regulation in hepatocytes. Ann N Y Acad Sci. 557:1989;46-59.
28. Agrawal A., Kilpatrick J.M., Volanakis J.E. Structure and function of human C-reactive protein. Mackiewicz A., Kushner I., Baumann H. Acute phase proteins. molecular biology, biochemistry, and clinical applications. 1993;79-92 CRC Press; Boca Raton.
29. Baumann H., Gauldie J. Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation. Mol Biol Med. 7:1990;147-159.
30. Banks R.E., Forbes M.A., Storr M.et al. The acute phase response in patients receiving subcutaneous IL-6. Clin Exp Immunol. 102:1995;217-223.
31. Papanicolaou D.A., Wilder R.L., Manolagas S.C.et al. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med. 128:1998;127-137.
32. Wener M.H., Daum P.R., McQuillan G.M. The influence of age, sex, and race on the upper reference limit of serum C-reactive protein concentration. J Rheumatol. 27:2000;2351-2359.
33. Ford E.S., Giles W.H. Serum C-reactive protein and self-reported stroke. finding from the Third National Health and Nutrition Examination Survey Arterioscler Thromb Vasc Biol. 20:2000;1052-1056.
34. Mohamed-Ali V., Goodrick S., Rawesh A.et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-[alpha], in vivo. J Clin Endocrinol Metab. 82:1997;4196-4200.
35. Fried S.K., Bunkin D.A., Greenberg A.S. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6. J Clin Endocrinol Metab. 83:1998;847-850.
36. Vgontzas A.N., Papanicolaou D.A., Bixler E.O.et al. Elevation of plasma cytokines in disorders of excessive daytime sleepiness. role of sleep disturbance and obesity J Clin Endocrinol Metab. 82:1997;1313-1316.
37. Warren R.S., Starnes H.F., Gabrilove J.L.et al. The acute metabolic effects of tumor necrosis factor administration in humans. Arch Surg. 122:1987;1396-1400.
38. Hirokawa J., Sakaue S., Furuya Y.et al. Tumor necrosis factor-alpha regulates the gene expression of macrophage migration inhibitory factor through tyrosine kinase-dependent pathway in 3t3-L1 adipocytes. J Biochem (Tokyo). 123:1998;733-739.
39. Hotamisligil G.S., Arner P., Caro J.F.et al. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest. 95:1995;2409-2415.
40. Kern P.A., Saghizadeh M., Ong J.M.et al. The expression of tumor necrosis factor in human adipose tissue. regulation by obesity, weight loss, and relationship to lipoprotein lipase J Clin Invest. 95:1995;2111-2119.